These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 28475832)

  • 21. Discovery of new
    Mehra R; Chib R; Munagala G; Yempalla KR; Khan IA; Singh PP; Khan FG; Nargotra A
    Mol Divers; 2015 Nov; 19(4):1003-19. PubMed ID: 26232029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan H; Doğan ŞD; Gündüz MG; Krishna VS; Lherbet C; Sriram D; Şahin O; Sarıpınar E
    Eur J Med Chem; 2020 Feb; 188():112035. PubMed ID: 31951850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diarylthiazole: an antimycobacterial scaffold potentially targeting PrrB-PrrA two-component system.
    Bellale E; Naik M; V B V; Ambady A; Narayan A; Ravishankar S; Ramachandran V; Kaur P; McLaughlin R; Whiteaker J; Morayya S; Guptha S; Sharma S; Raichurkar A; Awasthy D; Achar V; Vachaspati P; Bandodkar B; Panda M; Chatterji M
    J Med Chem; 2014 Aug; 57(15):6572-82. PubMed ID: 24967731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
    Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Mycobacterium tuberculosis CtpF as a target for designing new antituberculous compounds.
    Santos P; Lopez-Vallejo F; Ramírez D; Caballero J; Mata Espinosa D; Hernández-Pando R; Soto CY
    Bioorg Med Chem; 2020 Feb; 28(3):115256. PubMed ID: 31879181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleotide triphosphate promiscuity in Mycobacterium tuberculosis dethiobiotin synthetase.
    Salaemae W; Yap MY; Wegener KL; Booker GW; Wilce MC; Polyak SW
    Tuberculosis (Edinb); 2015 May; 95(3):259-66. PubMed ID: 25801336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of
    Singh S; Khare G; Bahal RK; Ghosh PC; Tyagi AK
    Drug Des Devel Ther; 2018; 12():1065-1079. PubMed ID: 29750019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Andrographolide: A potent antituberculosis compound that targets Aminoglycoside 2'-N-acetyltransferase in Mycobacterium tuberculosis.
    Prabu A; Hassan S; Prabuseenivasan ; Shainaba AS; Hanna LE; Kumar V
    J Mol Graph Model; 2015 Sep; 61():133-40. PubMed ID: 26245695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents.
    Chiarelli LR; Mori M; Barlocco D; Beretta G; Gelain A; Pini E; Porcino M; Mori G; Stelitano G; Costantino L; Lapillo M; Bonanni D; Poli G; Tuccinardi T; Villa S; Meneghetti F
    Eur J Med Chem; 2018 Jul; 155():754-763. PubMed ID: 29940465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
    Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase.
    Jung IP; Ha NR; Lee SC; Ryoo SW; Yoon MY
    Int J Antimicrob Agents; 2016 Sep; 48(3):247-58. PubMed ID: 27451857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead series.
    Ramachandran S; Panda M; Mukherjee K; Choudhury NR; Tantry SJ; Kedari CK; Ramachandran V; Sharma S; Ramya VK; Guptha S; Sambandamurthy VK
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4996-5001. PubMed ID: 23867166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors.
    Odell LR; Nilsson MT; Gising J; Lagerlund O; Muthas D; Nordqvist A; Karlén A; Larhed M
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4790-3. PubMed ID: 19560924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Target-Based Whole Cell Screen Approach To Identify Potential Inhibitors of Mycobacterium tuberculosis Signal Peptidase.
    Bonnett SA; Ollinger J; Chandrasekera S; Florio S; O'Malley T; Files M; Jee JA; Ahn J; Casey A; Ovechkina Y; Roberts D; Korkegian A; Parish T
    ACS Infect Dis; 2016 Dec; 2(12):893-902. PubMed ID: 27642770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of the salicylate synthase (MbtI) from Mycobacterium tuberculosis discovered by high-throughput screening.
    Vasan M; Neres J; Williams J; Wilson DJ; Teitelbaum AM; Remmel RP; Aldrich CC
    ChemMedChem; 2010 Dec; 5(12):2079-87. PubMed ID: 21053346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosis.
    Early JV; Casey A; Martinez-Grau MA; Gonzalez Valcarcel IC; Vieth M; Ollinger J; Bailey MA; Alling T; Files M; Ovechkina Y; Parish T
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3608-16. PubMed ID: 27044545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis.
    Matviiuk T; Madacki J; Mori G; Orena BS; Menendez C; Kysil A; André-Barrès C; Rodriguez F; Korduláková J; Mallet-Ladeira S; Voitenko Z; Pasca MR; Lherbet C; Baltas M
    Eur J Med Chem; 2016 Nov; 123():462-475. PubMed ID: 27490025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening of Antitubercular Compound Library Identifies Inhibitors of Mur Enzymes in
    Eniyan K; Rani J; Ramachandran S; Bhat R; Khan IA; Bajpai U
    SLAS Discov; 2020 Jan; 25(1):70-78. PubMed ID: 31597510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of a compound that acts as a bacterial PyrG (CTP synthase) inhibitor.
    Yoshida T; Nasu H; Namba E; Ubukata O; Yamashita M
    J Med Microbiol; 2012 Sep; 61(Pt 9):1280-1285. PubMed ID: 22700553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutamate Racemase Is the Primary Target of β-Chloro-d-Alanine in Mycobacterium tuberculosis.
    Prosser GA; Rodenburg A; Khoury H; de Chiara C; Howell S; Snijders AP; de Carvalho LP
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6091-9. PubMed ID: 27480853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.